Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Very powerful, his says not just saving lives but creating
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(33)
•••
Comment by barryt34on Nov 20, 2020 3:52pm
83 Views
Post# 31942883

RE:RE:Very powerful, his says not just saving lives but creating

RE:RE:Very powerful, his says not just saving lives but creating They also need the FDA approvals. In time it will come to light, one after the other, we have a lot coming down the pipeline.  A few of us on this board know we are on the edge of something game changing.   With the base established "lung transplant".  The technology will evolve into many different sectors. With the single drop of blood they will be able to test for many different infections and diseases.  The day will come, you feel sick, you have a device In your home. With a finger pric k it will tell you exactly what the problem is and how to cure it.  This is the technology.  Only my opinion and I'm a very optimistic person so take my comments with a grain of salt.  I truly believe this is where we are heading. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities